A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
Clinical trial NCT02295865 · COMPLETED
Trial details
- NCT number
- NCT02295865
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-17
- Primary completion
- 2016-03-11
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.